Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $123,942 - $137,908
593 Added 21.63%
3,335 $728,000
Q4 2023

Feb 12, 2024

SELL
$197.69 - $227.29 $18,582 - $21,365
-94 Reduced 3.31%
2,742 $623,000
Q2 2023

Aug 07, 2023

BUY
$211.93 - $241.33 $3,814 - $4,343
18 Added 0.64%
2,836 $684,000
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $20,372 - $24,897
100 Added 3.68%
2,818 $663,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $25,806 - $33,035
126 Added 4.86%
2,718 $557,000
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $63,088 - $81,971
295 Added 12.84%
2,592 $608,000
Q1 2022

May 04, 2022

BUY
$259.82 - $298.18 $44,689 - $51,286
172 Added 8.09%
2,297 $606,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $69,258 - $80,123
255 Added 13.64%
2,125 $668,000
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $1,923 - $2,158
-7 Reduced 0.37%
1,870 $526,000
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $1,763 - $1,946
7 Added 0.37%
1,877 $518,000
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $8,400 - $10,456
-41 Reduced 2.15%
1,870 $477,000
Q4 2020

Feb 11, 2021

SELL
$186.91 - $214.42 $6,168 - $7,075
-33 Reduced 1.7%
1,911 $389,000
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $6,848 - $8,253
41 Added 2.15%
1,944 $366,000
Q2 2020

Aug 11, 2020

BUY
$113.31 - $182.44 $36,599 - $58,928
323 Added 20.44%
1,903 $316,000
Q4 2019

Feb 11, 2020

SELL
$163.48 - $173.61 $92,856 - $98,610
-568 Reduced 26.44%
1,580 $267,000
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $52,724 - $58,773
330 Added 18.15%
2,148 $361,000
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $26,348 - $33,291
213 Added 13.27%
1,818 $278,000
Q4 2018

Feb 11, 2019

BUY
$120.82 - $174.09 $193,916 - $279,414
1,605 New
1,605 $203,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.